- call +1-201-465-4211
- email sales@mrinsights.biz
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
Scope of the Report:
In the last several years, global market of Microbiome Therapeutics developed rapidly, with an average growth rate of 98%. In 2017, Global Market Size of Microbiome Therapeutics is nearly 14 M USD.
For developing product, there are 2 products in Phase 3, 7 products in Phase 2, 8 products in Phase 1 and 17 products in Preclinical. The total investment for Microbiome Therapeutics developing is around 293 M USD in 2017.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI in 2016 is about 52%, and the proportion is in Increase trend from 2012 to 2016.
The worldwide market for Microbiome Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Microbiome Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Type I
Type II
Market Segment by Applications, can be divided into
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Microbiome Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Microbiome Therapeutics, with price, sales, revenue and global market share of Microbiome Therapeutics in 2017 and 2018.
Chapter 3, the Microbiome Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microbiome Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Microbiome Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Microbiome Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Type I
1.2.2 Type II
1.3 Market Analysis by Applications
1.3.1 Inflammatory Bowel Disease (IBD)
1.3.2 Orphan Drug
1.3.3 Immuno-oncology
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.2 Microbiome Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.2 Microbiome Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Interxon
2.4.1 Business Overview
2.4.2 Microbiome Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 PureTech
2.5.1 Business Overview
2.5.2 Microbiome Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Synlogic
2.6.1 Business Overview
2.6.2 Microbiome Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.2 Microbiome Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 4D Pharma
2.8.1 Business Overview
2.8.2 Microbiome Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Second Genome
2.9.1 Business Overview
2.9.2 Microbiome Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 AOBiome
2.10.1 Business Overview
2.10.2 Microbiome Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 Microbiome Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Microbiome Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 Microbiome Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Microbiome Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Microbiome Therapeutics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Microbiome Therapeutics Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 Microbiome Therapeutics Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Microbiome Therapeutics Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Microbiome Therapeutics Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.20 Osel
2.20.1 Business Overview
2.20.2 Microbiome Therapeutics Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.21 Metabogen
2.21.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Microbiome Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Microbiome Therapeutics Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Microbiome Therapeutics Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Microbiome Therapeutics Manufacturer Market Share in 2018
3.3.2 Top 6 Microbiome Therapeutics Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Microbiome Therapeutics Market Analysis by Regions
4.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Microbiome Therapeutics Sales and Market Share by Regions (2014-2019)
4.1.2 Global Microbiome Therapeutics Revenue and Market Share by Regions (2014-2019)
4.2 North America Microbiome Therapeutics Sales and Growth Rate (2014-2019)
4.3 Europe Microbiome Therapeutics Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Microbiome Therapeutics Sales and Growth Rate (2014-2019)
4.5 South America Microbiome Therapeutics Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Microbiome Therapeutics Sales and Growth Rate (2014-2019)
5 North America Microbiome Therapeutics by Country
5.1 North America Microbiome Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
5.1.2 North America Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
5.2 United States Microbiome Therapeutics Sales and Growth Rate (2014-2019)
5.3 Canada Microbiome Therapeutics Sales and Growth Rate (2014-2019)
5.4 Mexico Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6 Europe Microbiome Therapeutics by Country
6.1 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
6.1.2 Europe Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
6.2 Germany Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6.3 UK Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6.4 France Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6.5 Russia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
6.6 Italy Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7 Asia-Pacific Microbiome Therapeutics by Country
7.1 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
7.2 China Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7.3 Japan Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7.4 Korea Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7.5 India Microbiome Therapeutics Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
8 South America Microbiome Therapeutics by Country
8.1 South America Microbiome Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
8.1.2 South America Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
8.2 Brazil Microbiome Therapeutics Sales and Growth Rate (2014-2019)
8.3 Argentina Microbiome Therapeutics Sales and Growth Rate (2014-2019)
8.4 Colombia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9 Middle East and Africa Microbiome Therapeutics by Countries
9.1 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Microbiome Therapeutics Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Microbiome Therapeutics Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9.3 Turkey Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9.4 Egypt Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9.5 Nigeria Microbiome Therapeutics Sales and Growth Rate (2014-2019)
9.6 South Africa Microbiome Therapeutics Sales and Growth Rate (2014-2019)
10 Global Microbiome Therapeutics Market Segment by Type
10.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Microbiome Therapeutics Sales and Market Share by Type (2014-2019)
10.1.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Type I Sales Growth and Price
10.2.1 Global Type I Sales Growth (2014-2019)
10.2.2 Global Type I Price (2014-2019)
10.3 Type II Sales Growth and Price
10.3.1 Global Type II Sales Growth (2014-2019)
10.3.2 Global Type II Price (2014-2019)
11 Global Microbiome Therapeutics Market Segment by Application
11.1 Global Microbiome Therapeutics Sales Market Share by Application (2014-2019)
11.2 Inflammatory Bowel Disease (IBD) Sales Growth (2014-2019)
11.3 Orphan Drug Sales Growth (2014-2019)
11.4 Immuno-oncology Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Microbiome Therapeutics Market Forecast (2019-2024)
12.1 Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2019-2024)
12.2 Microbiome Therapeutics Market Forecast by Regions (2019-2024)
12.2.1 North America Microbiome Therapeutics Market Forecast (2019-2024)
12.2.2 Europe Microbiome Therapeutics Market Forecast (2019-2024)
12.2.3 Asia-Pacific Microbiome Therapeutics Market Forecast (2019-2024)
12.2.4 South America Microbiome Therapeutics Market Forecast (2019-2024)
12.2.5 Middle East and Africa Microbiome Therapeutics Market Forecast (2019-2024)
12.3 Microbiome Therapeutics Market Forecast by Type (2019-2024)
12.3.1 Global Microbiome Therapeutics Sales Forecast by Type (2019-2024)
12.3.2 Global Microbiome Therapeutics Market Share Forecast by Type (2019-2024)
12.4 Microbiome Therapeutics Market Forecast by Application (2019-2024)
12.4.1 Global Microbiome Therapeutics Sales Forecast by Application (2019-2024)
12.4.2 Global Microbiome Therapeutics Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure Global Sales Market Share of Microbiome Therapeutics by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
